Literature DB >> 3595598

Structural organization of the proopiomelanocortin gene in Xenopus laevis. 5'-end homologies within the toad and mammalian genes.

G J Martens.   

Abstract

This study reports the isolation and characterization of the entire proopiomelanocortin (POMC) gene of the amphibian Xenopus laevis. The Xenopus POMC gene consists of three exons of which the main exon 3 codes for all of the bioactive domains of the precursor protein. Intron A (2.6 kb) separates the segments encoding the 5'-untranslated mRNA region and intron B (2.5 kb) interrupts the protein-coding sequence near the signal peptide coding region. In that this structural organization of the Xenopus POMC gene is similar to those of the mammalian genes, apparently the POMC gene has been remarkably stable during 350 million years of vertebrate evolution. A comparative analysis of the 5'-flanking sequences of the Xenopus and mammalian POMC genes reveals the presence of several conserved regions. One of these regions is homologous with sequences located upstream of the capping sites of other glucocorticoid-regulated genes and another region contains a segment reminiscent of a viral enhancer consensus sequence.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595598     DOI: 10.1111/j.1432-1033.1987.tb11462.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  2 in total

1.  Compositional compartmentalization and gene composition in the genome of vertebrates.

Authors:  D Mouchiroud; G Fichant; G Bernardi
Journal:  J Mol Evol       Date:  1987       Impact factor: 2.395

2.  Comparative Functional Alanine Positional Scanning of the α-Melanocyte Stimulating Hormone and NDP-Melanocyte Stimulating Hormone Demonstrates Differential Structure-Activity Relationships at the Mouse Melanocortin Receptors.

Authors:  Aleksandar Todorovic; Mark D Ericson; Ryan D Palusak; Nicholas B Sorensen; Michael S Wood; Zhimin Xiang; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2016-05-17       Impact factor: 4.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.